SC 13G/A
Amended Statement of Ownership
Corbus Pharmaceuticals Holdings, Inc. Filed Acc 0000902664-24-006642
Stakes reported in this filing
Stake history · largest stake in each 13D and 13G
- 2026-11-13 SCHEDULE 13G · MPM BioImpact LLC 8.6%
- 2026-11-02 SCHEDULE 13G/A · Cormorant Asset Management, LP 7.76%
- 2026-10-29 SCHEDULE 13G/A · Aberdeen Group plc 0%
- 2026-09-30 SCHEDULE 13G · RA Capital Management, L.P. 9.9%
- 2026-08-14 SCHEDULE 13G/A · Citadel Securities LLC 1.1%
- 2026-07-27 SCHEDULE 13G · BlackRock, Inc. 5.9%
- 2026-05-14 SCHEDULE 13G/A · Octagon Capital Advisors LP 0.0%
- 2026-02-10 SCHEDULE 13G/A · Octagon Capital Advisors LP 5.4%
- 2026-01-16 SCHEDULE 13G · Aberdeen Group plc 7.53%
- 2025-12-15 SCHEDULE 13G/A · Cormorant Asset Management, LP 13.36%
- 2025-11-14 SCHEDULE 13G/A · Cormorant Asset Management, LP 12.82%
- 2025-11-12 SCHEDULE 13G · Kenneth Griffin 5.3%
- 2025-07-29 SCHEDULE 13G/A · The Vanguard Group 4.89%
Loading p24-3154sc13ga.htm…